Vilaprisan phase 2B trial: a timely efficacy and safety study of a novel selective progesterone receptor modulator for nonsurgical management of uterine fibroids

Reflections

Like Comment

Authors:

Julia L. Magnay, M.Sc.

Abstract:

Reflections on "Vilaprisan in women with uterine fibroids: randomized phase 2B ASTEROID 1 study" by Bradley et al.


Read the full text here.

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility┬« is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders.